EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Colchicine initiated before radiofrequency-induced injury attenuates left atrial inflammation, fibrosis, and susceptibility to atrial fibrillation

Abir Attia, Charles-Alexandre LeBlanc iD, Ewen Le Quilliec, Feng Xiong, Martin G Sirois, Jean-François Tanguay iD, Jean-Claude Tardif iD, Martin Aguilar iD, Roddy Hiram iD

Europace · 2026

DOI: 10.1093/europace/euag242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2026. Verfasst von Abir Attia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Montreal Heart Institute, Faculty of Medicine, 5000 Belanger Street Montreal, Université de Montreal, Montreal, Canada H1T 1C8. Hauptthemen laut MEDLINE: Colchicine, Atrial Fibrillation, Heart Atria, Catheter Ablation. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Montreal Heart Institute Foundation, Quebec Network for Research in Aging, Fonds de recherche du Québec.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Atrial fibrillation (AF) is the most frequently diagnosed cardiac arrhythmia. Catheter ablation using radiofrequency cauterization (CA-RFC) performed in the left atrium (LA) aims to isolate electrical sources of AF. This intervention is accompanied by frequent AF recurrences affecting 10% of patients at 30 days and 50% at one-year post-procedure. It has been suggested that inflammation could contribute to AF-recurrence post-CA-RFC. Given its anti-inflammatory and cardioprotective properties, colchicine has been proposed as a potential treatment to prevent AF recurrence post-CA-RFC. Hypothesis RFC can lead to atrial fibrosis, inflammation, and new-onset AF, which may be mitigated by colchicine. Methods and results Male and female Wistar rats (225–275 g) were divided into four groups: Sham or RFC, with or without colchicine (0.25 mg/kg/8 h, intraperitoneally) starting 8 h before surgery until D1 post-procedure. Sham animals underwent surgery without RFC. Electrophysiology and echocardiography assessments were performed on days 1 (D1) and 3 (D3) post-RFC. Colchicine significantly lowered RFC-induced AF vulnerability, improved LA conduction velocity, reduced LA fibrosis, and attenuated LA inflammation post-procedure. Colchicine also prevented RFC-induced CD11c+ macrophages while promoting CD206+ recruitment in the LA.

Conclusion

Colchicine started before RFC may be an innovative strategy to prevent the development of LA arrhythmogenic substrate post-procedure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineAtrial FibrillationHeart AtriaCatheter AblationAnti-Inflammatory AgentsAtrial RemodelingAnimalsFemaleFibrosisMaleRats, WistarDisease Models, AnimalRats

Stichwörter der Autor:innen

Atrial fibrillationAtrial inflammationCatheter ablationColchicineRadiofrequency Cauterization

Substanzen

ColchicineAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Montreal Heart Institute, Faculty of Medicine, 5000 Belanger Street Montreal, Université de Montreal, Montreal, Canada H1T 1C8.
  • Department of Medicine, Faculty of Medicine, Université de Montreal, Montreal, Canada.
  • Department of Medicine, Faculty of Medicine, 146 rue Léo Saignat, Université de Bordeaux, 33000 Bordeaux, France.
  • Department of Pharmacology and Physiology, Université de Montreal, Montreal, Canada.

ORCID-Profile: Charles-Alexandre LeBlanc, Jean-François Tanguay, Jean-Claude Tardif, Martin Aguilar, Roddy Hiram

Förderung

  • Montreal Heart Institute Foundation
  • Quebec Network for Research in Aging
  • Fonds de recherche du Québec
  • Canadian Foundation for Innovation
  • FRQ Early-career establishment

Zitieren

APA

Attia, A., LeBlanc, C. A., Le Quilliec, E., Xiong, F., Sirois, M. G., Tanguay, J. F., Tardif, J. C., Aguilar, M., & Hiram, R. (2026). Colchicine initiated before radiofrequency-induced injury attenuates left atrial inflammation, fibrosis, and susceptibility to atrial fibrillation. Europace. https://doi.org/10.1093/europace/euag242

Vancouver

Attia A, LeBlanc CA, Le Quilliec E, Xiong F, Sirois MG, Tanguay JF, et al. Colchicine initiated before radiofrequency-induced injury attenuates left atrial inflammation, fibrosis, and susceptibility to atrial fibrillation. Europace. 2026. doi:10.1093/europace/euag242

BibTeX
@article{Attia2026,
  author = {Attia, Abir and LeBlanc, Charles-Alexandre and Le Quilliec, Ewen and Xiong, Feng and Sirois, Martin G and Tanguay, Jean-François and Tardif, Jean-Claude and Aguilar, Martin and Hiram, Roddy},
  title = {Colchicine initiated before radiofrequency-induced injury attenuates left atrial inflammation, fibrosis, and susceptibility to atrial fibrillation},
  journal = {Europace},
  year = {2026},
  doi = {10.1093/europace/euag242}
}
Kostenlos starten →